The TGA has approved the Novavax COVID-19 vaccine for provisional use in Australia. Here’s what you need to know about it.
Yet another vaccine is now part of our arsenal of weapons against the covid-19 pandemic. On Saturday, the U.S. Food and Drug Administration granted an emergency use authorisation (EUA) to the one-dose shot developed by Johnson & Johnson. It joins the two-dose mRNA vaccines developed by Modern and Pfizer/BioNTech.